Killing of Rat Adenocarcinoma 13762in Situby Adoptive Transfer of CD4+ Anti-tumor T Cells Requires Tumor Expression of Cell Surface MHC Class II Molecules
AB Frey, S Cestari - Cellular immunology, 1997 - Elsevier
… killing of rat thymus cells in a final volume of 0.2 ml RPMI 1640 adenocarcinoma 13762 by
anti-tumor CD4/ T cells … ), anti-tumor T cell clones could recognize and kill tumor in situ (Fig.3).…
anti-tumor CD4/ T cells … ), anti-tumor T cell clones could recognize and kill tumor in situ (Fig.3).…
Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
AB Frey - Journal of immunology (Baltimore, Md.: 1950), 1995 - journals.aai.org
… reactivity with unmodified tumor in vitro, antitumor properties may … ified 13762 express cell
surface MHC class I1 molecules, … have been reported to express MHC class I1 in situ in certain …
surface MHC class I1 molecules, … have been reported to express MHC class I1 in situ in certain …
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen
DR Surman, ME Dudley, WW Overwijk… - The Journal of …, 2000 - journals.aai.org
… The anti-tumor effects of the CD4+ T cells required the presence of both MHC class I and class
II on host cells, … These results indicate that the apparent inability of tumor cells expressing …
II on host cells, … These results indicate that the apparent inability of tumor cells expressing …
Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
AB Frey - Journal of immunology (Baltimore, Md.: 1950), 1996 - journals.aai.org
… Ags in the context of cell surface MHC class I1 molecules. The … killing of tumor in situ by CD4'
T cells would require tumor … T-cell subsets in anti-tumor responses. Immunol. Today 8:267. …
T cells would require tumor … T-cell subsets in anti-tumor responses. Immunol. Today 8:267. …
… of activated H-rasval12 in nontumorigenic and non-cross-reactive syngeneic cells induces tumor antigens cross-reactive with rat mammary adenocarcinoma 13762.
AB Frey, S Cestari - Journal of immunology (Baltimore, Md.: 1950), 1995 - journals.aai.org
… irradiated cognate 13762 tumor requires functional CD4+ T cells (23). … cell surface MHC
class I molecules are expressed, 13762 … in situ) or provide help for other cytolytic effector cells. …
class I molecules are expressed, 13762 … in situ) or provide help for other cytolytic effector cells. …
Tumor-infiltrating macrophages induce apoptosis in activated CD8+ T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of …
M Saio, S Radoja, M Marino, AB Frey - The Journal of Immunology, 2001 - journals.aai.org
… . Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4 + anti-tumor T
cells requires tumor expression of cell surface MHC class II molecules. …
cells requires tumor expression of cell surface MHC class II molecules. …
Rat Adenocarcinoma 13762 Expresses Tumor Rejection Antigens but Tumor-Bearing Animals Exhibit Tumor-Specific Immunesuppression
AB Frey, LJ Appleman - Clinical immunology and immunopathology, 1993 - Elsevier
… with 13762 cells elicits a turnor-specific protective anti-tumor … Expression of TGF in situ by
13762 tumor is considered likely… M., Elimination of cycling CD4" suppressor T cells with an anti-…
13762 tumor is considered likely… M., Elimination of cycling CD4" suppressor T cells with an anti-…
Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by …
SD Hess, NK Egilmez, N Bailey… - The Journal of …, 2003 - journals.aai.org
… then surface stained with Abs to human CD45, CD3, and CD4 … microenvironment the cellular
and molecular events associated … . Rat mammary adenocarcinoma 13762 expressing IFN-γ …
and molecular events associated … . Rat mammary adenocarcinoma 13762 expressing IFN-γ …
[PDF][PDF] Tumor-Specific lmmunesuppression
AB FRE, ANLJ APPLEMAN - 1993 - academia.edu
… with 13762 cells elicits a turnor-specific protective anti-tumor … Expression of TGF in situ by
13762 tumor is considered likely… M., Elimination of cycling CD4" suppressor T cells with an anti-…
13762 tumor is considered likely… M., Elimination of cycling CD4" suppressor T cells with an anti-…
Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo
… T cells play a central role as immune effectors, CD4+ T cells act to control the activation and
persistence of the CD8+ T cell … required the de novo generation of P815AB-specific CD8+ T …
persistence of the CD8+ T cell … required the de novo generation of P815AB-specific CD8+ T …